Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Frontiers in Immunology|July 27, 2023
Bringing function to the forefront of cell therapy: how do we demonstrate potency?Mark W Lowdell, Ben WeilCytotherapy|January 11, 2025
Considerations for manufacturing of cell and gene medicines for clinical developmentMark W LowdellCytotherapy|January 4, 2023
Human platelet lysate enhances proliferation but not chondrogenic differentiation of pediatric mesenchymal progenitorsOliver F W Gardner, Natacha Agabalyan, Ben Weil, et al.Frontiers in Immunology|December 11, 2013
Tumor-primed NK cells: waiting for the green lightMay Sabry, Mark W LowdellBritish Journal of Haematology|October 18, 2016
The expanding role of the clinical haematologist in the new world of advanced therapy medicinal productsMark W Lowdell, Amy ThomasStem Cells Translational Medicine|May 17, 2020
Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancerMay Sabry, Mark W LowdellJACC. Case Reports|May 27, 2021
Allogeneic Mesenchymal Stromal Cell Injection to Alleviate Ischemic Heart Failure Following Arterial Switch OperationFilippo Rapetto, Demetris Taliotis, Qiang Chen, et al.Cytotherapy|July 18, 2012
Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cellsAndrea Knight, Stephen Mackinnon, Mark W LowdellCells|February 25, 2023
A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic SyndromeHelena Arellano-Ballestero, May Sabry, Mark W LowdellCytotherapy|March 27, 2019
Characterization of human natural killer cells for therapeutic useArnika K Wagner, Evren Alici, Mark W LowdellPageof 8